ticlopidine has been researched along with Carcinogenesis in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lack of differentiation in hepatocellular carcinoma (HCC) is associated with increased circulating platelet size." | 1.43 | Activated platelets inhibit hepatocellular carcinoma cell differentiation and promote tumor progression via platelet-tumor cell binding. ( Cheng, C; Guo, H; Li, B; Liu, Y; Liu, YJ; Xu, J; Zhang, R; Zhao, Y; Zhou, C, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, R | 1 |
| Guo, H | 1 |
| Xu, J | 1 |
| Li, B | 1 |
| Liu, YJ | 1 |
| Cheng, C | 1 |
| Zhou, C | 1 |
| Zhao, Y | 1 |
| Liu, Y | 1 |
1 other study available for ticlopidine and Carcinogenesis
| Article | Year |
|---|---|
Activated platelets inhibit hepatocellular carcinoma cell differentiation and promote tumor progression via platelet-tumor cell binding.
Topics: Adenosine Diphosphate; Aged; Animals; Blood Platelets; Carcinogenesis; Carcinoma, Hepatocellular; Ce | 2016 |